Modulation of inflammation and improvement in neurological outcome documented in this study are in line with previously published articles where either VEGF-C pre-treatment or the use of K14-vegfre-lg transgenic mice have highlighted the importance of VEGF-C in ischemic stroke [44, 61]. The gene discussed is KRT14; the disease is ischemic stroke.